SCHEMBL9744122

SCHEMBL9744122

CCOC(=O)[C@@H](C=C(C)CP(=O)(OC(C)C)OC(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 1/20 0.39
HTT P42858 1/20 0.39
CYP2D6 P10635 1/20 0.38
CTSK P43235 8/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CTSL P07711 1/20 0.34
CTSS P25774 1/20 0.34
ABCB1 P08183 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9743070 0.87 CA1 (0.37) CYP2D6CTSKCA1CA2CA7
SCHEMBL9744199 0.86 CYP2D6 (0.43) CYP2C9CYP2C19CYP2D6
SCHEMBL9840275 0.80 CTSK (0.40) CTSKCA1CA2CA7
SCHEMBL9743517 0.79 CYP2D6 (0.42) CYP2C9CYP2C19CYP2D6
SCHEMBL9743571 0.79 CYP2D6 (0.42) CYP2C9CYP2C19CYP2D6
SCHEMBL9744793 0.74 MEN1 (0.38) CTSKCA1CA2CA7CTSS
SCHEMBL9744035 0.74 CA1 (0.34) CYP2D6CTSKCA1CA2CA7
SCHEMBL10580459 0.71 CA1 (0.40) CYP2D6CTSKCA1CA2CA7
SCHEMBL23048008 0.69 CYP1A2 (0.42) SMN1; SMN2CYP2C9CYP2C19CYP1A2HTT
SCHEMBL11864461 0.69 NPSR1 (0.41) CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175344-A Anticonvulsants, anxiolytic agents CIBA-GEIGY CORPORATION (US) 1992-12-29 US disclosed
US-5051413-A For treatment of ischemia, antispasmodic agents, anticonvulsants and anxiety or manic conditions CIBA-GEIGY CORPORATION (US) 1991-09-24 US disclosed